Integra Holdings

Integra Holdings

Jerusalem, Jerusalem Districtintegra-holdings.com

Overview

Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success. Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience.

Year Founded

2012

AUM

$40M

Portfolio Companies

3

Investments

CompanyDateStageLead
Nectin TherapeuticsMay 2024Series ACo-investor
SpliSenseApr 2024StrategicCo-investor
Nectin TherapeuticsMay 2023VC RoundCo-investor
Nectin TherapeuticsNov 2022Series A Extension-
SpliSenseMay 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersJerusalem, Jerusalem District
Year Founded2012
AUM$40M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.